147 related articles for article (PubMed ID: 15383705)
1. The human-specific action of intermedilysin, a homolog of streptolysin O, is dictated by domain 4 of the protein.
Nagamune H; Ohkura K; Sukeno A; Cowan G; Mitchell TJ; Ito W; Ohnishi O; Hattori K; Yamato M; Hirota K; Miyake Y; Maeda T; Kourai H
Microbiol Immunol; 2004; 48(9):677-92. PubMed ID: 15383705
[TBL] [Abstract][Full Text] [Related]
2. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.
Soltani CE; Hotze EM; Johnson AE; Tweten RK
J Biol Chem; 2007 May; 282(21):15709-16. PubMed ID: 17412689
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
Ohkura K; Nagamune H; Kourai H
Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration.
Feil SC; Ascher DB; Kuiper MJ; Tweten RK; Parker MW
J Mol Biol; 2014 Feb; 426(4):785-92. PubMed ID: 24316049
[TBL] [Abstract][Full Text] [Related]
5. Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.
Hughes TR; Ross KS; Cowan GJ; Sivasankar B; Harris CL; Mitchell TJ; Morgan BP
Mol Immunol; 2009 Apr; 46(7):1561-7. PubMed ID: 19200600
[TBL] [Abstract][Full Text] [Related]
6. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin.
Polekhina G; Giddings KS; Tweten RK; Parker MW
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):600-5. PubMed ID: 15637162
[TBL] [Abstract][Full Text] [Related]
7. The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity.
Shewell LK; Harvey RM; Higgins MA; Day CJ; Hartley-Tassell LE; Chen AY; Gillen CM; James DB; Alonzo F; Torres VJ; Walker MJ; Paton AW; Paton JC; Jennings MP
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):E5312-20. PubMed ID: 25422425
[TBL] [Abstract][Full Text] [Related]
8. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.
Giddings KS; Zhao J; Sims PJ; Tweten RK
Nat Struct Mol Biol; 2004 Dec; 11(12):1173-8. PubMed ID: 15543155
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics of human-specific cytolysin: analysis of membrane binding motif for therapeutic application.
Ohkura K; Hori H; Nagamune H
Anticancer Res; 2006; 26(6A):4055-62. PubMed ID: 17195457
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary X-ray analysis of the human-specific toxin intermedilysin.
Polekhina G; Giddings KS; Tweten RK; Parker MW
Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):347-9. PubMed ID: 14747721
[TBL] [Abstract][Full Text] [Related]
11. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.
Nagamune H; Ohnishi C; Katsuura A; Fushitani K; Whiley RA; Tsuji A; Matsuda Y
Infect Immun; 1996 Aug; 64(8):3093-100. PubMed ID: 8757839
[TBL] [Abstract][Full Text] [Related]
12. The diversity of receptor recognition in cholesterol-dependent cytolysins.
Tabata A; Ohkura K; Ohkubo Y; Tomoyasu T; Ohkuni H; Whiley RA; Nagamune H
Microbiol Immunol; 2014 Mar; 58(3):155-71. PubMed ID: 24401114
[TBL] [Abstract][Full Text] [Related]
13. The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly.
Dowd KJ; Farrand AJ; Tweten RK
PLoS Pathog; 2012; 8(7):e1002787. PubMed ID: 22792065
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-binding cytolytic protein toxins.
Alouf JE
Int J Med Microbiol; 2000 Oct; 290(4-5):351-6. PubMed ID: 11111910
[TBL] [Abstract][Full Text] [Related]
15. Intermedilysin release by Streptococcus intermedius: effects of various antibacterial drugs at sub-MIC levels.
Taylor MB; Oh JH; Kang KL; Chow VT
FEMS Microbiol Lett; 2005 Feb; 243(2):379-84. PubMed ID: 15686838
[TBL] [Abstract][Full Text] [Related]
16. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
Wickham SE; Hotze EM; Farrand AJ; Polekhina G; Nero TL; Tomlinson S; Parker MW; Tweten RK
J Biol Chem; 2011 Jun; 286(23):20952-62. PubMed ID: 21507937
[TBL] [Abstract][Full Text] [Related]
17. Differential interaction of the two cholesterol-dependent, membrane-damaging toxins, streptolysin O and Vibrio cholerae cytolysin, with enantiomeric cholesterol.
Zitzer A; Westover EJ; Covey DF; Palmer M
FEBS Lett; 2003 Oct; 553(3):229-31. PubMed ID: 14572629
[TBL] [Abstract][Full Text] [Related]
18. Expression of active streptolysin O in Escherichia coli as a maltose-binding-protein--streptolysin-O fusion protein. The N-terminal 70 amino acids are not required for hemolytic activity.
Weller U; Müller L; Messner M; Palmer M; Valeva A; Tranum-Jensen J; Agrawal P; Biermann C; Döbereiner A; Kehoe MA; Bhakdi S
Eur J Biochem; 1996 Feb; 236(1):34-9. PubMed ID: 8617283
[TBL] [Abstract][Full Text] [Related]
19. The cholesterol-dependent cytolysin family of gram-positive bacterial toxins.
Heuck AP; Moe PC; Johnson BB
Subcell Biochem; 2010; 51():551-77. PubMed ID: 20213558
[TBL] [Abstract][Full Text] [Related]
20. A novel cholesterol-insensitive mode of membrane binding promotes cytolysin-mediated translocation by Streptolysin O.
Mozola CC; Magassa N; Caparon MG
Mol Microbiol; 2014 Nov; 94(3):675-87. PubMed ID: 25196983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
